From: Cost utility of a pharmacist-led minor ailment service compared with usual pharmacist care
Health resource | Mean model value | Std. error | Minimum | Maximuma | Source | Parametric distribution (PSA) |
---|---|---|---|---|---|---|
Costs | ||||||
 Pharmacist rate (per hour) | $29.37 | $2.52 | $24.04 | $34.30 | Australian Government Fair Work Ombudsman 2018 [40] | Gamma |
 Time to deliver MAS (minutes per patient) | 10.88 | 0.18 | 10.52 | 11.23 | cRCT data [29] | Normal |
 Time to deliver UC (minutes per patient) | 3.29 | 0.21 | 2.88 | 3.71 | cRCT data [29] | Normal |
 Trainings with MAS (number per year) | 1 | 0.51 | 0 | 2 | cRCT data [29] | Normal |
 Facilitator rate with MAS (per hour) | $46.28 | $4.72 | $37.02 | $55.54 | University of Technology Sydney award level HEW5 Step 1; cRCT data [29] | Gamma |
 Facilitator visits with MAS (per month) | 1 | 0.51 | 0 | 2 | cRCT data [29] | Normal |
 Average training, facilitation and technology cost with MAS (per patient) | $0.07 | $0.02 | $0.00 | $0.11 | Purchase invoices; cRCT data [29] | Gamma |
 Average nonprescription medicine price with MAS (per patient) | $10.62 | $0.22 | $10.20 | $11.05 | Amcal, Chemist Warehouse, Priceline 2019 data; cRCT data [29] | Gamma |
 Average nonprescription medicine price with UC (per patient) | $9.76 | $0.20 | $9.39 | $10.14 | Gamma | |
 Average cost of medicines at reconsult (per patient) | $9.79 | $0.94 | $7.94 | $11.64 | PBS 2019; Amcal, Chemist Warehouse, Priceline 2019 data; cRCT data [29] | Gamma |
 General practitioner fee (per consult) | $44.07 | $6.74 | $30.85 | $57.29 | MBS 2019 [46] | Gamma |
Probabilities | ||||||
 Symptom resolution (MAS) | 0.75 | 0.02 | 0.73 | 0.77 | cRCT data [29] | Beta |
 Appropriate pharmacist care (MAS) | 0.87 | 0.01 | 0.85 | 0.88 | cRCT data [29] | Beta |
 Symptom resolution (UC) | 0.74 | 0.02 | 0.65 | 0.69 | cRCT data [29] | Beta |
 Appropriate pharmacist care (UC) | 0.68 | 0.02 | 0.71 | 0.76 | cRCT data [29] | Beta |
Utilities | ||||||
 Symptom resolution | 0.91 | 0.02 | 0.88 | 0.94 | Refer to Watson study [25] | Beta |
 No symptom resolution | 0.77 | 0.02 | 0.73 | 0.81 | Beta |